BRPI0922132A2 - fragmentos glutamil trna sintetase (gts). - Google Patents

fragmentos glutamil trna sintetase (gts).

Info

Publication number
BRPI0922132A2
BRPI0922132A2 BRPI0922132A BRPI0922132A BRPI0922132A2 BR PI0922132 A2 BRPI0922132 A2 BR PI0922132A2 BR PI0922132 A BRPI0922132 A BR PI0922132A BR PI0922132 A BRPI0922132 A BR PI0922132A BR PI0922132 A2 BRPI0922132 A2 BR PI0922132A2
Authority
BR
Brazil
Prior art keywords
gts
trna synthetase
synthetase fragments
glutamyl trna
glutamyl
Prior art date
Application number
BRPI0922132A
Other languages
English (en)
Inventor
Tal Michael
Dagan Ron
Mizrachinebenzahl Yaffa
Original Assignee
Protea Vaccine Tech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Protea Vaccine Tech Ltd filed Critical Protea Vaccine Tech Ltd
Publication of BRPI0922132A2 publication Critical patent/BRPI0922132A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
BRPI0922132A 2008-12-03 2009-12-03 fragmentos glutamil trna sintetase (gts). BRPI0922132A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11938308P 2008-12-03 2008-12-03
PCT/IL2009/001142 WO2010064243A1 (en) 2008-12-03 2009-12-03 GLUTAMYL tRNA SYNTHETASE (GtS) FRAGMENTS

Publications (1)

Publication Number Publication Date
BRPI0922132A2 true BRPI0922132A2 (pt) 2018-10-23

Family

ID=42041695

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0922132A BRPI0922132A2 (pt) 2008-12-03 2009-12-03 fragmentos glutamil trna sintetase (gts).

Country Status (9)

Country Link
US (1) US20110236470A1 (pt)
EP (1) EP2356225A1 (pt)
JP (1) JP2012510289A (pt)
KR (1) KR20110091560A (pt)
CN (1) CN102239253A (pt)
AU (1) AU2009323682A1 (pt)
BR (1) BRPI0922132A2 (pt)
CA (1) CA2745205A1 (pt)
WO (1) WO2010064243A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010064232A2 (en) * 2008-12-03 2010-06-10 Ben Gurion University Of The Negev Research And Development Authority USES OF GLUTAMYL tRNA SYNTHETASE (GtS) FRAGMENTS
BRPI1011919A2 (pt) 2009-06-29 2017-09-26 Childrens Medical Center vacinas e composições contra streptococcus pneumoniae
EP2566492B1 (en) 2010-05-04 2016-10-26 aTyr Pharma, Inc. Innovative discovery of therapeutic compositions related to protein fragments of glutamyl-prolyl-trna synthetases
AU2012207089B2 (en) 2011-01-20 2016-04-14 Children's Medical Center Corporation Vaccines and compositions against Streptococcus pneumoniae
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
KR20220082558A (ko) * 2020-12-10 2022-06-17 재단법인 의약바이오컨버젼스연구단 면역 증진 활성이 있는 신규 crs 단편 펩타이드 및 이의 용도

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767842A (en) 1973-05-07 1988-08-30 The Ohio State University Antigenic modification of polypeptides
US4436727A (en) 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4539205A (en) 1982-11-09 1985-09-03 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US4643992A (en) 1982-11-09 1987-02-17 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US5093318A (en) 1983-11-01 1992-03-03 Scripps Clinic And Research Foundation Immunostimulating guanosine derivatives and their pharmaceutical compositions
US5011828A (en) 1985-11-15 1991-04-30 Michael Goodman Immunostimulating guanine derivatives, compositions and methods
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
CA2017507C (en) 1989-05-25 1996-11-12 Gary Van Nest Adjuvant formulation comprising a submicron oil droplet emulsion
US5709879A (en) 1990-06-29 1998-01-20 Chiron Corporation Vaccine compositions containing liposomes
ATE156710T1 (de) 1992-06-25 1997-08-15 Smithkline Beecham Biolog Adjuvantien enthaltende impfstoffzusammensetzung
ATE157882T1 (de) 1993-03-23 1997-09-15 Smithkline Beecham Biolog 3-0-deazylierte monophosphoryl lipid a enthaltende impfstoff-zusammensetzungen
GB9326253D0 (en) 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
US6194388B1 (en) 1994-07-15 2001-02-27 The University Of Iowa Research Foundation Immunomodulatory oligonucleotides
UA56132C2 (uk) 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
CO4600681A1 (es) 1996-02-24 1998-05-08 Boehringer Ingelheim Pharma Composicion farmaceutica para la modulacion inmunitaria
US5958734A (en) 1997-04-18 1999-09-28 Smithkline Beecham Corporation Polynucleotides encoding gluS polypeptides of streptococcus pneumoniae
US5976840A (en) 1997-04-18 1999-11-02 Smithkline Beecham Corporation Polynucleotides encoding gluS polypeptides of streptococcal pneumoniae
GB9607992D0 (en) 1996-04-18 1996-06-19 Smithkline Beecham Plc Novel compounds
US6355257B1 (en) 1997-05-08 2002-03-12 Corixa Corporation Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
US6113918A (en) 1997-05-08 2000-09-05 Ribi Immunochem Research, Inc. Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
US7063967B2 (en) 1997-05-08 2006-06-20 Corixa Corporation Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
US6303347B1 (en) 1997-05-08 2001-10-16 Corixa Corporation Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
US6080725A (en) 1997-05-20 2000-06-27 Galenica Pharmaceuticals, Inc. Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
CA2290646C (en) 1997-05-20 2008-03-11 Galenica Pharmaceuticals, Inc. Triterpene saponin analogs having adjuvant and immunostimulatory activity
CA2302554C (en) 1997-09-05 2007-04-10 Smithkline Beecham Biologicals S.A. Oil in water emulsions containing saponins
ATE215385T1 (de) 1997-12-16 2002-04-15 Chiron Corp Verwendung von mikropartikeln mit submikron öl/wasser emulsionen
KR20010042573A (ko) 1998-04-09 2001-05-25 장 스테판느 애쥬번트 조성물
WO1999056776A2 (en) 1998-05-07 1999-11-11 Corixa Corporation Adjuvant composition and methods for its use
GB0107658D0 (en) 2001-03-27 2001-05-16 Chiron Spa Streptococcus pneumoniae
WO2003082183A2 (en) * 2002-04-02 2003-10-09 Ben-Gurion University Of The Negev Research And Development Authority Protein-based streptococcus pneumoniae vaccines

Also Published As

Publication number Publication date
US20110236470A1 (en) 2011-09-29
WO2010064243A1 (en) 2010-06-10
CA2745205A1 (en) 2010-06-10
EP2356225A1 (en) 2011-08-17
KR20110091560A (ko) 2011-08-11
CN102239253A (zh) 2011-11-09
JP2012510289A (ja) 2012-05-10
AU2009323682A1 (en) 2010-06-10

Similar Documents

Publication Publication Date Title
BRPI1010653A2 (pt) refrigerador.
BRPI1007047A2 (pt) Biorrefino irganosolv de cana-de-açúcar inteira.
BRPI1011275A2 (pt) refrigerador.
FR2929502B1 (fr) Implant nucleique.
BRPI1008684A2 (pt) queimador de gás.
BRPI1014650A2 (pt) molas espiral-em-espiral e molas interiores.
BRPI0912260A2 (pt) tonalizador.
BRPI1016117A2 (pt) derivados de isoxazol-isoxazol e isoxasol-isotiazol.
BRPI1010579A2 (pt) espiro-oxetano nucleosídeos de uracila.
FR2942517B1 (fr) Materiau compliant.
IT1396487B1 (it) Convogliatore.
BRPI1016192A2 (pt) derivados de soxazol.
DK2442870T3 (da) Pyrazinooxazepin-derivater.
BRPI0922132A2 (pt) fragmentos glutamil trna sintetase (gts).
BR112012001062A2 (pt) laminados com microtextura.
BRPI0907448A2 (pt) Instrumentos.
FR2950402B1 (fr) Collier de serrage.
BR112012002612A2 (pt) calha.
BRPI1008952A2 (pt) Composição herbicida.
BRPI0922477A2 (pt) transportador.
IT1396642B1 (it) Statore.
IT1396781B1 (it) Piano di cottura.
BR112012000911A2 (pt) biomarcador.
IT1394665B1 (it) Granitore.
ITME20080002A1 (it) Filcomplex - potabilizzatore di acque.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]